How many insider trades does FilingIQ track for FLGT?

FilingIQ tracks 534 Form 4 insider transactions for FLGT (Fulgent Genetics, Inc.), covering filings from Apr 13, 2016 onwards. 48 of those were filed in the last 90 days.

Are FLGT insiders net buyers or net sellers?

Across the full Form 4 history for FLGT, 18 transactions (3%) were open-market purchases and 153 (29%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does FLGT insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is FLGT in?

Fulgent Genetics, Inc. (FLGT) is classified in the Healthcare sector, specifically Diagnostics & Research, with a current market capitalisation of $725.51M.

FLGT insider trading

NasdaqGM Healthcare

Fulgent Genetics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

534

Last 90 days

Buys / sells

3% / 29%

Market cap

$725.51M

About Fulgent Genetics, Inc.

Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. The company was founded in 2011 and is headquartered in El Monte, California.

Company website: www.fulgentgenetics.com

FLGT insider activity at a glance

FilingIQ has scored 534 insider transactions for FLGT since Apr 13, 2016. The most recent filing in our index is dated Apr 26, 2026.

Across the full history, 18 open-market purchases and 153 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on FLGT insider trades is 56.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live FLGT trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for FLGT?: FilingIQ tracks 534 Form 4 insider transactions for FLGT (Fulgent Genetics, Inc.), covering filings from Apr 13, 2016 onwards. 48 of those were filed in the last 90 days.
Are FLGT insiders net buyers or net sellers?: Across the full Form 4 history for FLGT, 18 transactions (3%) were open-market purchases and 153 (29%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does FLGT insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is FLGT in?: Fulgent Genetics, Inc. (FLGT) is classified in the Healthcare sector, specifically Diagnostics & Research, with a current market capitalisation of $725.51M.

Methodology & sources

Every FLGT insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.